Viewing Study NCT00859105


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-06-29 @ 2:57 AM
Study NCT ID: NCT00859105
Status: COMPLETED
Last Update Posted: 2009-03-10
First Post: 2009-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
Sponsor: Apotex Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Actinic Keratosis View
Keywords: